The Relationship Between Peripartum Cardiomyopathy and Preeclampsia – Pathogenesis, Diagnosis and Management

References

• Pearson GD, Veille JC, Rahimtoola S, et al. Peripartum cardiomyopathy: national heart, lung, and blood institute and office of rare diseases (national institutes of health) workshop recommendations and review. JAMA. 2000;283(9):1183–1188. doi:10.1001/jama.283.9.1183
   PubMed Web of Science ®Google Scholar
• Hibbard JU, Lindheimer M, Lang RM. A modified definition for peripartum cardiomyopathy and prognosis based on echocardiography. Obstet Gynecol. 1999;94:311–316. doi:10.1016/s0029-7844(99)00293-8
   PubMed Web of Science ®Google Scholar
• Sliwa K, Hilfiker-Kleiner D, Petrie MC, et al. Heart failure association of the European society of cardiology working group on peripartum cardiomyopathy. current state of knowledge on aetiology, diagnosis, management, and therapy of peripartum cardiomyopathy: a position statement from the heart failure association of the European society of cardiology working group on peripartum cardiomyopathy. Eur J Heart Fail. 2010;12:767–778. doi:10.1093/eurjhf/hfq120
   PubMed Web of Science ®Google Scholar
• Elkayam U, Akhter MW, Singh H, et al. Pregnancy-associated cardiomyopathy: clinical characteristics and a comparison between early and late presentation. Circulation. 2005;111(16):2050–2055. doi:10.1161/01.CIR.0000162478.36652.7E
   PubMed Web of Science ®Google Scholar
• Polskie Towarzystwo Kardiologiczne. Guidelines of the European Society of Cardiology (ESC) and the European Society of Hypertension (ESH); 2018. Available from: https://ptkardio.pl/wytyczne/1-wytyczne_escesh_dotyczace_postepowania_w_nadcisnieniu_tetniczym. Accessed April 20, 2022.
   Google Scholar
• Hull E, Hidden E. Postpartal heart failure. South Med J. 1938;31:265–270. doi:10.1097/00007611-193803000-00010
   Google Scholar
• Demakis JG, Rahimtoola SH. Peripartum cardiomyopathy. Circulation. 1971;44(5):964–968. doi:10.1161/01.CIR.44.5.964
   PubMed Web of Science ®Google Scholar
• Gunderson EP, Croen LA, Chiang V, et al. Epidemiology of peripartum cardiomyopathy: incidence, predictors, and outcomes. Obstet Gynecol. 2011;118:583–591. doi:10.1097/AOG.0b013e318229e6de
   PubMed Web of Science ®Google Scholar
• Bauer ST, Cleary KL. Cardiopulmonary complications of pre-eclampsia. Semin Perinatol. 2009;33(3):158–165. doi:10.1053/j.semperi.2009.02.008
   PubMed Web of Science ®Google Scholar
• Parikh P, Blauwet L. Peripartum cardiomyopathy and preeclampsia: overlapping diseases of pregnancy. Curr Hypertens Rep. 2018;20(8):69. doi:10.1007/s11906-018-0868-9
   PubMed Web of Science ®Google Scholar
• Brar SS, Khan SS, Sandhu GK, et al. Incidence, mortality, and racial differences in peripartum cardiomyopathy. Am J Cardiol. 2007;100(2):302–304. doi:10.1016/j.amjcard.2007.02.092
   PubMed Web of Science ®Google Scholar
• Kolte D, Khera S, Aronow WS, et al. Temporal trends in incidence and outcomes of peripartum cardiomyopathy in the United States: a nationwide population-based study. J Am Heart Assoc. 2014;3(3):e001056. doi:10.1161/JAHA.114.001056
   PubMed Web of Science ®Google Scholar
• Fett JD, Carraway RD, Dowell DL, et al. Peripartum cardiomyopathy in the Hospital Albert Schweitzer District of Haiti. Am J Obstet Gynecol. 2002;186:1005–1010. doi:10.1067/mob.2002.122423
   PubMed Web of Science ®Google Scholar
• Mielniczuk LM, Williams K, Davis DR. Frequency of peripartum cardiomyopathy. Am J Cardiol. 2006;97(12):1765–1768. doi:10.1016/j.amjcard.2006.01.039
   PubMed Web of Science ®Google Scholar
• Krishnamoorthy P, Garg J, Palaniswamy C, et al. and outcomes of peripartum cardiomyopathy in the United States: findings from the Nationwide Inpatient Sample. J Cardiovasc Med. 2016;17(10):756–761. doi:10.2459/JCM.0000000000000222
   Google Scholar
• Wu VC, Chen TH, Yeh JK, et al. Clinical outcomes of peripartum cardiomyopathy: a 15-year nationwide population-based study in Asia. Medicine. 2017;96(43):e8374. doi:10.1097/MD.0000000000008374
   PubMed Web of Science ®Google Scholar
• Barasa A, Rosengren A, Sandström TZ, et al. Heart failure in late pregnancy and postpartum: incidence and long-term mortality in Sweden from 1997 to 2010. J Card Fail. 2017;23(5):370–378. doi:10.1016/j.cardfail.2016.12.011
   PubMed Web of Science ®Google Scholar
• Lee S, Cho GJ, Park GU, et al. Incidence, risk factors, and clinical characteristics of peripartum cardiomyopathy in South Korea. Circ Heart Fail. 2018;11(4):e004134. doi:10.1161/CIRCHEARTFAILURE.117.004134
   PubMed Web of Science ®Google Scholar
• Melamed N, Ray JG, Hladunewich M, et al. Gestational hypertension and preeclampsia: are they the same disease? J Obstet Gynaecol Can. 2014;36(7):642–647. doi:10.1016/S1701-2163(15)30545-4
   PubMedGoogle Scholar
• Bello N, Rendon ISH, Arany Z. The relationship between pre-eclampsia and peripartum cardiomyopathy: a systematic review and meta-analysis. J Am Coll Cardiol. 2013;62:1715–1723. doi:10.1016/j.jacc.2013.08.717
   PubMed Web of Science ®Google Scholar
• Sliwa K, Mebazaa A, Hilfiker-Kleiner D, et al. Clinical characteristics of patients from the worldwide registry on peripartum cardiomyopathy (PPCM): eurobservational research programme in conjunction with the heart failure association of the European society of cardiology study group on PPCM. Eur J Heart Fail. 2017;19(9):1131–1141. doi:10.1002/ejhf.780
   PubMed Web of Science ®Google Scholar
• Reuwer AQ, Reuwer PJ, van der Post JA, et al. Twickler Prolactin fragmentation by trophoblastic matrix metalloproteinases as a possible contributor to peripartum cardiomyopathy and pre-eclampsia. Med Hypotheses. 2010;74:348–352. doi:10.1016/j.mehy.2009.08.029
   PubMed Web of Science ®Google Scholar
• Young BC, Levine RJ, Karumanchi SA. Pathogenesis of preeclampsia. Annu Rev Pathol. 2010;5(1):173–192. doi:10.1146/annurev-pathol-121808-102149
   PubMed Web of Science ®Google Scholar
• Patten IS, Rana S, Shahul S, et al. Cardiac angiogenic imbalance leads to peripartum cardiomyopathy. Nature. 2012;485(7398):333–338. doi:10.1038/nature11040
   PubMed Web of Science ®Google Scholar
• Fett JD. Peripartum cardiomyopathy: a puzzle closer to solution. World J Cardiol. 2014;6(3):87–99. doi:10.4330/wjc.v6.i3.87
   PubMedGoogle Scholar
• Nguyen KA, Gniady K, Lelonek M. Peripartum cardiomyopathy — still unknown Current State of Knowledge. Folia Cardiologica. 2019;14:305–314. doi:10.5603/FC.2019.0064
   Google Scholar
• Verlohren S, Herraiz I, Lapaire O, et al. New gestational phase-specific cutoff values for the use of the soluble fms-like tyrosine kinase-1/placental growth factor ratio as a diagnostic test for preeclampsia. Hypertension. 2014;63:346–352. doi:10.1161/HYPERTENSIONAHA.113.01787
   PubMed Web of Science ®Google Scholar
• Patel PA, Hernandez AF. Targeting anti-beta-1-adrenergic receptor antibodies for dilated cardiomyopathy. Eur J Heart Fail. 2013;15:724–729. doi:10.1093/eurjhf/hft065
   PubMed Web of Science ®Google Scholar
• Maynard SE, Min JY, Merchan J, et al. Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest. 2003;111:649–658.
   PubMed Web of Science ®Google Scholar
• Ahmad S, Ahmed A. Elevated placental soluble vascular endothelial growth factor receptor-1 inhibits angiogenesis in preeclampsia. Circ Res. 2004;95(9):884–891. doi:10.1161/01.RES.0000147365.86159.f5
   PubMed Web of Science ®Google Scholar
• Rana S, Hacker MR, Modest AM, et al. Circulating angiogenic factors and risk of adverse maternal and perinatal outcomes in twin pregnancies with suspected preeclampsia. Hypertension. 2012;60(2):451–458. doi:10.1161/HYPERTENSIONAHA.112.195065
   PubMed Web of Science ®Google Scholar
• Taylor BD, Ness RB, Klebanoff MA, et al. First and second trimester immune biomarkers in pre-eclamptic and normotensive women. Pregnancy Hypertens. 2016;6(4):388–393. doi:10.1016/j.preghy.2016.09.002
   PubMed Web of Science ®Google Scholar
• Charkiewicz K, Jasinska E, Goscik J, et al. Angiogenic factor screening in women with mild preeclampsia—new and significant proteins in plasma. Cytokine. 2017;106:125–130. doi:10.1016/j.cyto.2017.10.020
   PubMed Web of Science ®Google Scholar
• Kaitu’u-Lino TJ, Brownfoot FC, Hastie R, et al. Activating transcription factor 3 is reduced in preeclamptic placentas and negatively regulates sFlt-1 (soluble fms-like tyrosine kinase 1), soluble endoglin, and proinflammatory cytokines in placenta. Hypertension. 2017;70(5):1014–1024. doi:10.1161/HYPERTENSIONAHA.117.09548
   PubMed Web of Science ®Google Scholar
• Agachan B, Attar R, Isbilen E, et al. Association of monocyte chemotactic protein-1 and CC chemokine receptor 2 gene variants with preeclampsia. J Interf Cytokine Res. 2010;30(9):673–676. doi:10.1089/jir.2010.0008
   PubMed Web of Science ®Google Scholar
• Ricke-Hoch M, Bultmann I, Stapel B, et al. Opposing roles of Akt and STAT3 in the protection of the maternal heart from peripartum stress. Cardiovasc Res. 2014;101(4):587–596. doi:10.1093/cvr/cvu010
   PubMed Web of Science ®Google Scholar
• American College of Obstetricians, Gynecologists, Task Force on Hypertension in P. Hypertension in pregnancy. Report of the American college of obstetricians and gynecologists’task force on hypertension in pregnancy. Obstet Gynecol. 2013;122(5):1122–1131. doi:10.1097/01.AOG.0000437382.03963.88
   PubMed Web of Science ®Google Scholar
• Hilfiker-Kleiner D, Kaminski K, Podewski E, et al. A cathepsin D-cleaved 16 kDa form of prolactin mediates postpartum cardiomyopathy. Cell. 2007;128(3):589–600. doi:10.1016/j.cell.2006.12.036
   PubMed Web of Science ®Google Scholar
• Blauwet LA, Cooper LT. Diagnosis and management of peripartum cardiomyopathy. Heart. 2011;97(23):1970–1981. doi:10.1136/heartjnl-2011-300349
   PubMed Web of Science ®Google Scholar
• Visser W, Wallenburg HC. Central hemodynamic observations in untreated preeclamptic patients. Hypertension. 1991;17(6 Pt 2):1072–1077. doi:10.1161/01.HYP.17.6.1072
   PubMed Web of Science ®Google Scholar
• Bosio PM, McKenna PJ, Conroy R, et al. Maternal central hemodynamics in hypertensive disorders of pregnancy. Obstet Gynecol. 1999;94(6):978–984. doi:10.1016/s0029-7844(99)00430-5
   PubMed Web of Science ®Google Scholar
• Sibai BM, Mabie WC. Hemodynamics of preeclampsia. Clin Perinatol. 1991;18(4):727–747. doi:10.1016/S0095-5108(18)30493-7
   PubMed Web of Science ®Google Scholar
• Dennis AT, Castro J, Carr C, et al. Haemodynamics in women with untreated pre-eclampsia. Anaesthesia. 2012;67(10):1105–1118. doi:10.1111/j.1365-2044.2012.07193.x
   PubMed Web of Science ®Google Scholar
• Timpka S, Macdonald-Wallis C, Hughes AD, et al. Hypertensive disorders of pregnancy and offspring cardiac structure and function in adolescence. J Am Heart Assoc. 2016;5(11):e003906. doi:10.1161/JAHA.116.003906
   PubMed Web of Science ®Google Scholar
• Mutlu K, Karadas U, Yozgat Y, et al. Echocardiographic evaluation of cardiac functions in newborns of mildly preeclamptic pregnant women within postnatal 24–48 hours. J Obstet Gynaecol. 2018;38(1):16–21. doi:10.1080/01443615.2017.1322564
   PubMedGoogle Scholar
• Ntusi NB, Badri M, Gumedze F, et al. Pregnancy-associated heart failure: a comparison of clinical presentation and outcome between hypertensive heart failure of pregnancy and idiopathic peripartum cardiomyopathy. PLoS One. 2015;10(8):e0133466. doi:10.1371/journal.pone.0133466
   PubMed Web of Science ®Google Scholar
• Lindley KJ, Conner SN, Cahill AG, et al. Impact of preeclampsia on clinical and functional outcomes in women with peripartum cardiomyopathy. Circ Heart Fail. 2017;10(6):e003797. doi:10.1161/CIRCHEARTFAILURE.116.003797
   PubMed Web of Science ®Google Scholar
• Haghikia A, Podewski E, Libhaber E, et al. Phenotyping and outcome on contemporary management in a German cohort of patients with peripartum cardiomyopathy. Basic Res Cardiol. 2013;108(4):366. doi:10.1007/s00395-013-0366-9
   PubMed Web of Science ®Google Scholar
• Li W, Li H, Long Y. Clinical characteristics and long-term predictors of persistent left ventricular systolic dysfunction in peripartum cardiomyopathy. Can J Cardiol. 2016;32(3):362–368. doi:10.1016/j.cjca.2015.07.733
   PubMed Web of Science ®Google Scholar
• Blauwet LA, Delgado-Montero A, Ryo K, et al. Right ventricular function in peripartum cardiomyopathy at presentation is associated with subsequent left ventricular recovery and clinical outcomes. Circ Heart Fail. 2016;9(5):e002756. doi:10.1161/CIRCHEARTFAILURE.115.002756
   PubMed Web of Science ®Google Scholar
• Haghikia A, Rontgen P, Vogel-Claussen J, et al. Prognostic implication of right ventricular involvement in peripartum cardiomyopathy: a cardiovascular magnetic resonance study. ESC Heart Fail. 2015;2(4):139–149. doi:10.1002/ehf2.12059
   PubMed Web of Science ®Google Scholar
• Bhattacharyya A, Basra SS, Sen P, et al. Peripartum cardiomyopathy: a review. Tex Heart Inst J. 2012;39:8–16.
   PubMed Web of Science ®Google Scholar
• Demakis JG, Rahimtoola SH, Sutton GC, et al. Natural course of peripartum cardiomyopathy. Circulation. 1971;44:1053–1061. doi:10.1161/01.cir.44.6.1053
   PubMed Web of Science ®Google Scholar
• Hsu YC, Huang ST, Ho ST, et al. An unusual case of peripartum cardiomyopathy in a parturient with preeclampsia. Acta Anaesthesiol Taiwan. 2010;48(1):33–36. doi:10.1016/S1875-4597(10)60007-0
   PubMedGoogle Scholar
• Lampert MB, Lang RM. Peripartum cardiomyopathy. Am Heart J. 1995;130:860–870. doi:10.1016/0002-8703(95)90089-6
   PubMed Web of Science ®Google Scholar
• Elkayam U. Clinical characteristics of peripartum cardiomyopathy in the United States: diagnosis, prognosis, and management. J Am Coll Cardiol. 2011;58(7):659–670. doi:10.1016/j.jacc.2011.03.047
   PubMed Web of Science ®Google Scholar
• Sliwa K, Fett JD, Elkayam U. Peripartum cardiomyopathy. Lancet. 2006;368:687–693. doi:10.1016/S0140-6736(06)69253-2
   PubMed Web of Science ®Google Scholar
• Honigberg MC, Givertz MM. Peripartum cardiomyopathy. BMJ. 2019;30(364):k5287. doi:10.1136/bmj.k5287
   Web of Science ®Google Scholar
• Vázquez-Rodríguez JG, Veloz-Martínez MG. Pleural effusion and ascites in severe preeclampsia: frequency and correlation with plasma colloid osmotic pressure and renal filtration function. Cir Cir. 2011;79:299–305.
   PubMed Web of Science ®Google Scholar
• Puri A, Sethi R, Singh B, et al. Peripartum cardiomyopathy presenting with ventricular tachycardia: a rare presentation. Indian Pacing Electrophysiol J. 2009;9:186–189.
   PubMedGoogle Scholar
• Gemici G, Tezcan H, Fak AS, et al. Peripartum cardiomyopathy presenting with repetitive monomorphic ventricular tachycardia. Pacing Clin Electrophysiol. 2004;27:557–558. doi:10.1111/j.1540-8159.2004.00483.x
   PubMed Web of Science ®Google Scholar
• Manikkan A, Sanati M. Peripartum cardiomyopathy presenting as splenic infarct. J Hosp Med. 2008;3(3):274–276. doi:10.1002/jhm.281
   PubMed Web of Science ®Google Scholar
• Thangaratinam S, Gallos ID, Meah N, et al. TIPPS (tests in prediction of pre-eclampsia’s severity) review group how accurate are maternal symptoms in predicting impending complications in women with preeclampsia? a systematic review and meta-analysis. Acta Obstet Gynecol Scand. 2011;90(6):564–573.
   PubMed Web of Science ®Google Scholar
• Gestational Hypertension and. Preeclampsia: ACOG practice bulletin, number 222. Obstet Gynecol. 2020;135(6):e237–e260. doi:10.1097/AOG.0000000000003891
   PubMed Web of Science ®Google Scholar
• Sperling JD, Dahlke JD, Huber WJ, et al. The role of headache in the classification and management of hypertensive disorders in pregnancy. Obstet Gynecol. 2015;126:297–302. doi:10.1097/AOG.0000000000000966
   PubMed Web of Science ®Google Scholar
• Butalia S, Audibert F, Côté A-M, et al. Hypertension Canada’s 2018 guidelines for the management of hypertension in pregnancy. Can J Cardiol. 2018;34(5):3–526. doi:10.1016/j.cjca.2018.02.021
   Web of Science ®Google Scholar
• Toppenberg KS, Hill DA, Miller DP. Safety of radiographic imaging during pregnancy. Am Fam Physician. 1999;59:1813–1818.
   PubMed Web of Science ®Google Scholar
• Murali S, Baldisseri MR. Peripartum cardiomyopathy. Crit Care Med. 2005;33:S340–S346.
   PubMed Web of Science ®Google Scholar
• Zimmermann O, Kochs M, Zwaka TP, et al. Myocardial biopsy based classification and treatment in patients with dilated cardiomyopathy. Int J Cardiol. 2005;104(1):92–100. doi:10.1016/j.ijcard.2005.02.052
   PubMed Web of Science ®Google Scholar
• Surdacki A, Bednarek J, Kruszelnicka O, et al. Przewlekła niewydolność serca (PNS). Medycyna Praktyczna; 2021. Available from: https://www.mp.pl/interna/chapter/B16.II.2.19.1.#74967. Accessed April 20, 2022.
   Google Scholar
• Marmursztejn J, Vignaux O, Goffinet F, et al. Delayed-enhanced cardiac magnetic resonance imaging features in peripartum cardiomyopathy. Int J Cardiol. 2009;137(3):e63–4. doi:10.1016/j.ijcard.2009.04.028
   PubMed Web of Science ®Google Scholar
• Mouquet F, Lions C, de Groote P, et al. Characterisation of peripartum cardiomyopathy by cardiac magnetic resonance imaging. Eur Radiol. 2008;18(12):2765–2769. doi:10.1007/s00330-008-1067-x
   PubMed Web of Science ®Google Scholar
• Enriquez AD, Economy KE, Tedrow UB. Contemporary management of arrhythmias during pregnancy. Circ Arrhythm Electrophysiol. 2014;7:961–967. doi:10.1161/CIRCEP.114.001517
   PubMed Web of Science ®Google Scholar
• Ommen SR, Mital S, Burke MA, et al. American Heart Association. 2020 AHA/ACC guideline for the diagnosis and treatment of patients with hypertrophic cardiomyopathy. J Am Coll Cardiol. 2020;76(25):212.
   Web of Science ®Google Scholar
• Jeejeebhoy FM, Zelop CM, Lipman S, et al. American heart association emergency cardiovascular care committee, council on cardiopulmonary, critical care, perioperative and resuscitation, council on cardiovascular diseases in the young, and council on clinical cardiology cardiac arrest in pregnancy: a scientific statement from the American heart association. Circulation. 2015;132(18):1747–1773.
   PubMed Web of Science ®Google Scholar
• McNamara DM, Holubkov R, Starling RC, et al. Controlled trial of intravenous immune globulin in recent-onset dilated cardiomyopathy. Circulation. 2001;103(18):2254–2259. doi:10.1161/01.CIR.103.18.2254
   PubMed Web of Science ®Google Scholar
• James AH, Jamison MG, Brancazio LR, et al. Venous thromboembolism during pregnancy and the postpartum period: incidence, risk factors, and mortality. Am J Obstet Gynecol. 2006;194(5):1311–1315. doi:10.1016/j.ajog.2005.11.008
   PubMed Web of Science ®Google Scholar
• Pyatt JR, Dubey G. Peripartum cardiomyopathy: current understanding, comprehensive management review and new developments. Postgrad Med J. 2011;87(1023):34–39. doi:10.1136/pgmj.2009.096594
   PubMed Web of Science ®Google Scholar
• Bozkurt B, Colvin M, Cook J, et al. American heart association committee on heart failure and transplantation of the council on clinical cardiology; council on cardiovascular disease in the young; council on cardiovascular and stroke nursing; council on epidemiology and prevention; and council on quality of care and outcomes research current diagnostic and treatment strategies for specific dilated cardiomyopathies: a scientific statement from the American heart association. Circulation. 2016;134(23):e579–e646.
   PubMedGoogle Scholar
• Regitz-Zagrosek V, Roos-Hesselink JW, Bauersachs J, et al. 2018 ESC guidelines for the management of cardiovascular diseases during pregnancy. Eur Heart J. 2018;39(34):3165–3241. doi:10.1093/eurheartj/ehy340
   PubMed Web of Science ®Google Scholar
• Hilfiker-Kleiner D, Haghikia A, Berliner D, et al. Bromocriptine for the treatment of peripartum cardiomyopathy: a multicentre randomized study. Eur Heart J. 2017;38(35):2671–2679. doi:10.1093/eurheartj/ehx355
   PubMed Web of Science ®Google Scholar
• Bauersachs J, Arrigo M, Hilfiker-Kleiner D, et al. Current management of patients with severe acute peripartum cardiomyopathy: practical guidance from the heart failure association of the European Society of Cardiology Study Group on peripartum cardiomyopathy. Eur J Heart Fail. 2016;18(9):1096–1105. doi:10.1002/ejhf.586
   PubMed Web of Science ®Google Scholar
• Velickovic IA, Leicht CH. Peripartum cardiomyopathy and cesarean section: report of two cases and literature review. Arch Gynecol Obstet. 2004;270(4):307–310. doi:10.1007/s00404-003-0568-8
   PubMedGoogle Scholar
• Canobbio MM, Warnes CA, Aboulhosn J, et al. American heart association council on cardiovascular and stroke nursing; council on clinical cardiology; council on cardiovascular disease in the young; council on functional genomics and translational biology; and council on quality of care and outcomes research management of pregnancy in patients with complex congenital heart disease: a scientific statement for healthcare professionals from the American heart association. Circulation. 2017;135(8):e50–e87.
   PubMed Web of Science ®Google Scholar
• Stergiopoulos K, Shiang E, Bench T. Pregnancy in patients with pre-existing cardiomyopathies. J Am Coll Cardiol. 2011;58(4):337–350. doi:10.1016/j.jacc.2011.04.014
   PubMed Web of Science ®Google Scholar
• Felker GM, Jaeger CJ, Klodas E, et al. Myocarditis and long-term survival in peripartum cardiomyopathy. Am Heart J. 2000;140(5):785–791. doi:10.1067/mhj.2000.110091
   PubMed Web of Science ®Google Scholar
• Fett JD, Sannon H, Thélisma E, et al. Recovery from severe heart failure following peripartum cardiomyopathy. Int J Gynaecol Obstet. 2009;104(2):125–127. doi:10.1016/j.ijgo.2008.09.017
   PubMed Web of Science ®Google Scholar
• Yaméogo NV, Kaboré E, Seghda A, et al. Embolie pulmonaire grave et ischémie aiguë de membre inférieur compliquant une cardiomyopathie du péripartum traitées avec succès par thrombolyse à la streptokinase [Severe pulmonary embolism and acute lower limb ischemia complicating peripartum cardiomyopathy successfully treated by streptokinase]. Ann Cardiol Angeio. 2016;65(1):38–41. French.
   PubMedGoogle Scholar
• Abdulbaki A, Kocherla C, Modi K. Aspiration thrombectomy in a case of acute myocardial infarction due to coronary emboli in a patient with peripartum cardiomyopathy and mural thrombus. Heart Int. 2016;10:e25–7. doi:10.5301/heartint.5000225
   PubMedGoogle Scholar
• Kharwar RB, Chandra S, Dwivedi SK, et al. A pedunculated left ventricular thrombus in a women with peripartum cardiomyopathy: evaluation by three dimensional echocardiography. J Cardiovasc Ultrasound. 2014;22(3):139–143. doi:10.4250/jcu.2014.22.3.139
   PubMedGoogle Scholar
• US Department of health and human services. Available from: http://optn.transplant.hrsa.gov/latestData/rptData.asp. Accessed August 30, 2013.
   Google Scholar
• Sliwa K, Skudicky D, Bergemann A, et al. Peripartum cardiomyopathy: analysis of clinical outcome, left ventricular function, plasma levels of cytokines and Fas/APO-1. J Am Coll Cardiol. 2000;35(3):701–705. doi:10.1016/S0735-1097(99)00624-5
   PubMed Web of Science ®Google Scholar
• Clark SJ, Kahn K, Houle B, et al. Young children’s probability of dying before and after their mother’s death: a rural South African population-based surveillance study. PLoS Med. 2013;10(3):e1001409. doi:10.1371/journal.pmed.1001409
   PubMed Web of Science ®Google Scholar
• Fett JD, Murphy JG. Infant survival in Haiti after maternal death from peripartum cardiomyopathy. Int J Gynaecol Obstet. 2006;94(2):135–136. doi:10.1016/j.ijgo.2006.05.009
   PubMed Web of Science ®Google Scholar
• Kamiya CA, Kitakaze M, Ishibashi-Ueda H, et al. Different characteristics of peripartum cardiomyopathy between patients complicated with and without hypertensive disorders. -Results from the Japanese Nationwide survey of peripartum cardiomyopathy. Circ J. 2011;75(8):1975–1981. doi:10.1253/circj.CJ-10-1214
   PubMed Web of Science ®Google Scholar
• Barasa A, Goloskokova V, Ladfors L, et al. Symptomatic recovery and pharmacological management in a clinical cohort with peripartum cardiomyopathy. J Matern Fetal Neonatal Med. 2018;31(10):1342–1349. doi:10.1080/14767058.2017.1317341
   PubMed Web of Science ®Google Scholar
• Seeho SK, Algert CS, Roberts CL, et al. Early-onset preeclampsia appears to discourage subsequent pregnancy but the risks may be overestimated. Am J Obstet Gynecol. 2016;215(6):785.e1–785.e8. doi:10.1016/j.ajog.2016.07.038
   PubMed Web of Science ®Google Scholar
• Codsi E, Rose CH, Blauwet LA. Subsequent pregnancy outcomes in patients with peripartum cardiomyopathy. Obstet Gynecol. 2018;131(2):322–327. doi:10.1097/AOG.0000000000002439
   PubMed Web of Science ®Google Scholar
• Guldbrandt Hauge M, Johansen M, Vejlstrup N, et al. Subsequent reproductive outcome among women with peripartum cardiomyopathy: a nationwide study. BJOG. 2018;125(8):1018–1025. doi:10.1111/1471-0528.15046
   PubMed Web of Science ®Google Scholar
• Heider AL, Kuller JA, Strauss RA, et al. Peripartum cardiomyopathy: a review of the literature. Obstet Gynecol Surv. 1999;54(8):526–531. doi:10.1097/00006254-199908000-00023
   PubMedGoogle Scholar
• Elkayam U, Tummala PP, Rao K, et al. Maternal and fetal outcomes of subsequent pregnancies in women with peripartum cardiomyopathy. N Engl J Med. 2001;344(21):1567–1571. doi:10.1056/NEJM200105243442101
   PubMed Web of Science ®Google Scholar
• Avila WS, de Carvalho ME, Tschaen CK, et al. Pregnancy and peripartum cardiomyopathy. A comparative and prospective study. Arq Bras Cardiol. 2002;79(5):484–493. doi:10.1590/S0066-782X2002001400006
   PubMedGoogle Scholar
• Sliwa K, Petrie MC, Hilfiker-Kleiner D, et al. Long-term prognosis, subsequent pregnancy, contraception and overall management of peripartum cardiomyopathy: practical guidance paper from the heart failure association of the European society of cardiology study group on peripartum cardiomyopathy. Eur J Heart Fail. 2018;20(6):951–962. doi:10.1002/ejhf.1178
   PubMed Web of Science ®Google Scholar
• American Heart Association (AHA). Classes of heart failure; 2017. Available from: https://www.heart.org/en/health-topics/heart-failure/what-is-heart-failure/classes-of-heart-failure. Accessed April 20, 2022.
   Google Scholar
• Sliwa K, Förster O, Libhaber E, et al. Peripartum cardiomyopathy: inflammatory markers as predictors of outcome in 100 prospectively studied patients. Eur Heart J. 2006;27(4):441–446. doi:10.1093/eurheartj/ehi481
   PubMed Web of Science ®Google Scholar